Abstract
Various vascular and valvlular grafts are commonly used in the treatment of cardiovascular disease. Current prosthetic or bioprosthetic materials lack growth potential, and therefore, subsequent replacement further defeats the concept of primary repair early in pediatric cardiac patients. Tissue engineering is a new discipline that offers the potential to create replacement structures from autologous cells and biodegradable polymer scaffolds. Because tissue-engineering constructs contain living cells, they may have the potential for growth, self-repair, and self-remodeling. Cardiac valve leaflets and large conduits in the pulmonary ciruulation have been made with this tissue-engineering approach in lambs. Venous conduits were also created in dogs. Mixed cell populations of endothelial cells and fibroblasts were isolated from explanted peripheral arteries or vein. A synthetic biodegradable scaffold con-sisting of polyglactin and polyglycolic acid fibers was seeded in vitro with mixed cultured cells. After one week, these autologous cell/polymer constructs were reimplanted in animals. Each animal was then followed periodically by echocardiography and angiography. The animals were sacrificed, and the implanted tissues were examined histologically, biochemically, and biomechanically. A 4-hydroxyproline assay was performed to evaluate the collagen content. The implanted conduit diameters increased as the animals grew during the study period. Histologically, the biodegradable polymer scaffold was completely degraded. Collagen analysis of the constructs showed the development of an extracellular matrix. Immunohistochemical staining demonstrated elastin fiber in the matrix and factor VIII on the inner surface of the conduits. In conclusion, a tissue-engineering approach to constructing cardiovascular structures is feasible using cells of either arterial or venous origin. In these tissue-engineered autografts, transplanted autologous cells generated the proper matrix over the polymer scaffold under physiologic conditions.
Similar content being viewed by others
References
Langer R, Vacanti JP. Tissue engineering. Science, 1993;260:920–926
Kirklin J, Barratt-Boyes B. Ventricular septal defect and pulmonary stenosis or atresia. In: Kirklin J, Barrat-Boyes B (eds) Cardiac surgery. New York: Churchill Livingstone, 1993;861–1012
Braunwald E. Valvular heart disease. In: Braunwald E (ed) Heart disease. 5th ed. Philadelphia: Saunders, 1992;1007–1076
Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–641
Carpentier A. Congenital malformations of the mitral valve. In: Stark J, de Levcal M (eds) Surgery for congenital heart defects. 2nd ed. London: Grune & Stratton, 1983;599–614
Kirklin JK, Smith D, Novick W, Naffel DC, Kirklin JW, Pacifico A, Nanda NC, Helmeke FR, Bourge RC. Long-term function of cryopreserved aortic homografts. J Thorac Cardiovasc Surg 1993;106:154–166
Shin'Oka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:551–553
Shin'Oka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr. Creation of viable pulmonary autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536–545
Shin'Oka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996;94(suppl II):
Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961–1965
Booyse FM, Sedlak BJ, Rafelson M Jr. Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb Diath Haemorrh 1975;34:825–839
Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science 1999;284:489–493
Kim BS, Nikolovski J, Bonadio J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nature Biotech 1999;17:979–981
Huynh T, Abraham G, Murray J. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nature Biotech 1999;17:1083–1085
Nerem RM, Braddon LG, Seliktar D. Tissue engineering and the vascular system. In: Atala A, Mooney DJ (eds) Synthetic Biodegradable polymer scaffolds. Boston: Birkhauser, 1997;165–185
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shin'oka, T., Imai, Y., Watanabe, M. et al. Current status of tissue engineering for cardiovascular structures. J Artif Organs 3, 102–106 (2000). https://doi.org/10.1007/BF02479974
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02479974